Walter

Susan G. Komen® Breast Cancer Research Awards Presented To Exceptional Breast Cancer Physician Scientists And Research Advocate

Retrieved on: 
Wednesday, December 6, 2023
Woman, Walter, Global Health, Liver cancer, Ron Link (patient advocate), Patient, Research, Radiation therapy, Funding of science, Prognosis, Cancer, Oncology, Doctor of Philosophy, Recurrence, Quality of life, Vanderbilt University Medical Center, University, Division, Dana–Farber Cancer Institute, MBBS, Harvard Medical School, Genetics, FACP, SAN, Breast cancer, Dean (education), Clinical research, Mentorship, Survivor, University of Chicago, Liquid biopsy, Associate, Disease, Flexner Report, Internal medicine, MPH, Neoplasm, Birth control, Medical imaging, Dietary supplement, Pharmaceutical industry, Science, Basic research, Medicine, MD

SAN ANTONIO, Dec. 6, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, will present awards to four dedicated physician scientists and a pioneering research advocate for their work to drive discoveries and improve breast cancer patient outcomes. They will be recognized tonight at the Susan G. Komen Breast Cancer Research Awards event in San Antonio.

Key Points: 
  • SAN ANTONIO, Dec. 6, 2023 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization, will present awards to four dedicated physician scientists and a pioneering research advocate for their work to drive discoveries and improve breast cancer patient outcomes.
  • They will be recognized tonight at the Susan G. Komen Breast Cancer Research Awards event in San Antonio.
  • This evening's awardees have made significant contributions in breast cancer research and clinical practice, both of which are critical to fighting this disease.
  • They have advanced our understanding of the mechanisms underlying the genesis of breast cancer (Basic Science) and have pioneered advances in breast cancer care (Clinical Research).

Introducing World Precision Instruments' Scientific Advisory Board: A Team of Experts Driving Innovation in Scientific Research and Drug Development

Retrieved on: 
Friday, November 10, 2023
Toronto Metropolitan University, Drug development, Research, Associate professor, Walter, Assistant professor, University of Central Florida, Central Florida, Pregnancy, SAB, Biomedical Research, University, WPI, CITES, Knowledge, Medical device, Management

Comprised of renowned experts in various scientific disciplines, the SAB will play a crucial role in guiding and advancing WPI's commitment to innovation and excellence in scientific research.

Key Points: 
  • Comprised of renowned experts in various scientific disciplines, the SAB will play a crucial role in guiding and advancing WPI's commitment to innovation and excellence in scientific research.
  • World Precision Instrument is proud to announce the establishment of its Scientific Advisory Board.
  • "We are thrilled to welcome such a distinguished group of scientists to our Scientific Advisory Board," said Dr. Adrienne Watson, Chief Scientific Officer of WPI.
  • The SAB will collaborate closely with WPI's research and development teams, fostering a dynamic exchange of ideas and knowledge.

Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

Retrieved on: 
Monday, November 6, 2023
HBIO, Washington Convention Center, MEA, Pharmacology, Organoid, Behavior, EST, Toxicology, Microelectrode array, Product management, Research, ChromeOS, Data management, Society, Environment, Harvard Bioscience, Walter, Electrophysiology, Safety, Area studies, Telemetry, Neuropharmacology, DSI, Management, Neuroscience

HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C.

Key Points: 
  • HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C.
  • The latest advancements from the Company’s Data Sciences International (DSI) preclinical business expand the reach of DSI’s industry-leading, GLP-compliant Ponemah™ preclinical data management platform.
  • These advancements include DSI’s new SoHo™ implantable telemetry solution for small animal models and its VivaMARS™ high-capacity behavior monitoring system.
  • Representatives will be present during exhibit hours from Sunday November 12, 2023 through Wednesday November 15, 2023 from 9.30 a.m. to 5.00 p.m. EST.

Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023

Retrieved on: 
Thursday, November 2, 2023
Science, Washington Convention Center, FDA, IND, Schulich School of Medicine & Dentistry, Chemotherapy-induced peripheral neuropathy, Food, Neuropathic pain, Health, News, Walter E. Washington Convention Center, Research, Poster, Society, Walter, CIPN, University, Depression, Cancer, Anxiety, D.C, Pain, Diabetic neuropathy, Cannabidiol, FABP5, Investigational New Drug, Food and Drug Administration, Pharmaceutical industry, Neuroscience

Another poster will present work on Artelo’s proprietary cocrystal of cannabidiol and tetramethylpyrazine, ART12.11, which has demonstrated improved efficacy and bioavailability compared to cannabidiol alone in a model of anxiety and depression.

Key Points: 
  • Another poster will present work on Artelo’s proprietary cocrystal of cannabidiol and tetramethylpyrazine, ART12.11, which has demonstrated improved efficacy and bioavailability compared to cannabidiol alone in a model of anxiety and depression.
  • “We are very pleased to have two of our programs being featured at this year’s conference,” commented Dr. Andrew Yates, Chief Scientific Officer at Artelo Biosciences.
  • ART26.12 has demonstrated a positive effect in numerous animal models of painful neuropathies, including chemotherapy-induced peripheral neuropathy (CIPN) and diabetic neuropathy.
  • For more information about the conference, please visit Neuroscience 2023 .

Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023

Retrieved on: 
Friday, October 27, 2023
Washington Convention Center, Alzheimer's disease, AFL, Rare, Spinocerebellar ataxia, HD, Autophagy, Mouse, Tauopathy, Research fellow, Walter, Huntington's disease, Society, Therapy, Dietary supplement, ALS, Neuroscience

NEW YORK, Oct. 27, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has been selected to present a poster from a study of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous infusion) in a tauopathy model of Alzheimer's disease at the Society for Neuroscience's Neuroscience 2023 meeting, to be held on November 11-15, 2023, at the Walter E. Washington Convention Center in Washington, D.C.

Key Points: 
  • In this model, tauopathy was induced in older non-human primates (NHPs) through double-tau mutations introduced in entorhinal cortex bilaterally.
  • NfL is a non-specific biomarker for several neurodegenerative conditions, including Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
  • This has now been demonstrated in two aggressive and fast progressing neurodegenerative disease models of Huntington's disease and Alzheimer's disease across two species, mice and non-human primates, respectively," said Krishna Subramanian, Ph.D., Vice President, Non-Clinical Development and Translational Science at Seelos.
  • Seelos will present a poster on Monday, November 13, 2023 at 9:00 a.m.

Landmark African American Art Gift Donated To Telfair Museums

Retrieved on: 
Tuesday, October 24, 2023
Linda, Nexus, American Landscape, Beach, Telfair Museums, Exhibition, Friends, SCAD Museum of Art, Savannah College of Art and Design, History, Motivation, Publication, Black studies, Acquisition, The arts, Telfair Academy, Walter, Retirement, Museum, SCAD, Collection, Jacob, Book, Beauty, Interior design, Management, Tourism, Transit, Telfair, Black, Savanna, Art

The Evanses are donating 30 works to the South’s oldest public art museum, including historical and contemporary paintings, prints, drawings, photographs, and sculptures by leading figures in the field of African American art.

Key Points: 
  • The Evanses are donating 30 works to the South’s oldest public art museum, including historical and contemporary paintings, prints, drawings, photographs, and sculptures by leading figures in the field of African American art.
  • “This donation by Walter and Linda Evans represents the single most transformative gift to Telfair’s permanent collection in the museum’s history,” says Director and CEO Ben Simons.
  • The Evans Collection gift aligns perfectly with our strategic goal to embrace and to fully represent our community.”
    Dr. Evans, a Savannah-born surgeon, began collecting African American art in the late 1970s while living in Detroit, Michigan.
  • These two annual lectures, free to the public, bring to Savannah leading Black artists and top scholars on African American art, often in conjunction with museum exhibitions.

Events DC Named to EXHIBITOR Magazine’s Centers of Excellence List for the Fifth Year in a Row

Retrieved on: 
Tuesday, October 24, 2023
Washington Convention Center, Events DC, Convention center, Event, Health, Customer, LEED, News, Certification, Wi-Fi, Gold, Taiwan Excellence Awards, Walter, Walter E. Washington Convention Center, Partnership, Safety, Film industry, Tourism

Washington, DC, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Events DC, the official convention and sports authority for Washington, DC announced that the Walter E. Washington Convention Center was named one of North America’s best convention centers for trade shows and events by Exhibitor Group for the fifth year in a row.

Key Points: 
  • Washington, DC, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Events DC, the official convention and sports authority for Washington, DC announced that the Walter E. Washington Convention Center was named one of North America’s best convention centers for trade shows and events by Exhibitor Group for the fifth year in a row.
  • The Walter E. Washington Convention Center is also a finalist for the Best Convention Center Award (500,000 – 1 million square-feet of exhibit space) and Best Customer Service Award.
  • “Being named to EXHIBITOR’s Centers of Excellence list for the fifth year in a row is remarkable,” said Events DC President and CEO Angie M. Gates.
  • In addition, the Convention Center will host the 2024 Business Events Industry Week from April 9 through 11 in partnership with Events DC and Destination DC.

OSS to Showcase Specialized High-Performance AI Computing Solutions at AUSA 2023 on October 9-11

Retrieved on: 
Thursday, October 5, 2023
Annual general meeting, GPU, OSS, AI, Association of the United States Army, United States Air Force, Walter, Defense, United States Department of the Army, AUSA, Walter E. Washington Convention Center, Washington Convention Center, PCI Express, 3U, SDS, U.S. Department of Defense Strategy for Operating in Cyberspace, Atmosphere, Arms industry

ESCONDIDO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (Nasdaq: OSS), a leader in AI Transportable solutions on the edge, will showcase its specialized high-performance AI computing solutions at the Association of the United States Army (AUSA) Annual Meeting , the largest land power exposition and professional development forum in North America.

Key Points: 
  • ESCONDIDO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (Nasdaq: OSS), a leader in AI Transportable solutions on the edge, will showcase its specialized high-performance AI computing solutions at the Association of the United States Army (AUSA) Annual Meeting , the largest land power exposition and professional development forum in North America.
  • The event is being held at the Walter E. Washington Convention Center in Arlington, Virgina on October 9-11, 2023.
  • OSS sales representatives will demonstrate the company’s specialized solutions, including customized edge servers, compute accelerators, flash storage arrays and expansion systems.
  • Visitors to AUSA 2023 can see OSS AI Transportable systems at booth 7507.

CACI Showcases Expertise and Technology for the U.S. Army's Multi-Domain Force

Retrieved on: 
Monday, October 9, 2023
Data Management, Aerospace, Technology, Manufacturing, Security, Other Technology, Software, Other Defense, Networks, Defense, Contracts, Army, NYSE, Digital transformation, Information International, Inc., Risk, Walter, NSA, Digital, AUSA, Integrated Personnel and Pay System - Army, CACI, News, Washington Convention Center, Hall, RET, Internet service provider, United States Army, DevOps

To maintain a competitive edge in all domains, the Army is increasingly turning to data-driven, software-enabled solutions that deliver decisive information advantage.

Key Points: 
  • To maintain a competitive edge in all domains, the Army is increasingly turning to data-driven, software-enabled solutions that deliver decisive information advantage.
  • ), senior vice president for Technology and Solutions about how CACI is Building a Data-Driven Army to Achieve Information Advantage .
  • During the exposition, CACI will host The CACI Concierge where soldiers can find information about the Integrated Personnel and Pay System-Army (IPPS-A) .
  • Follow CACI on LinkedIn and X (Twitter) for the latest news and information during AUSA.

WRAIR, VA and MitoSense Announce Collaborative Research Agreement to Develop Novel Prehospital Treatment for Traumatic Brain Injury

Retrieved on: 
Wednesday, October 11, 2023
Partnership, TBI, Centers for Disease Control and Prevention, Walter Reed Army Institute of Research, Neuroprotection, Development, Organization, Therapy, Injury, Death, Walter, Traumatic brain injury, Hospital, WRAIR, CRADA, Patient, Nursing, Medical device, Veteran

Traumatic brain injury poses a major medical challenge for both military and civilian populations.

Key Points: 
  • Traumatic brain injury poses a major medical challenge for both military and civilian populations.
  • "This collaboration aligns with our mission to develop mitochondrial therapeutics for injuries and diseases that desperately need new treatment options."
  • "VA research focuses on the needs of Veterans, which includes traumatic brain injury," said Dr. Mark S. Kindy, VA Principal Investigator.
  • "This CRADA provides an exciting opportunity to evaluate a novel prehospital treatment that could protect brain function after injury."